The spike protein (S) of SARS coronavirus (SARS-CoV) attaches the virus to its cellular
receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain …

The coronavirus spike (S) protein mediates infection of receptor-expressing host cells and is
a critical target for antiviral neutralizing antibodies. Angiotensin-converting enzyme 2 (ACE2) …

Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute
respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their …

The entry of the SARS coronavirus (SCV) into cells is initiated by binding of its spike
envelope glycoprotein (S) to a receptor, ACE2. We and others identified the receptor-binding …

Cell entry of severe acute respiratory syndrome coronavirus (SARS-CoV) is mediated by the
viral spike (S) protein. Amino acids 319–510 on the S protein have been mapped as the …

The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (CoV), a
type I transmembrane envelope glycoprotein, consists of S1 and S2 domains responsible for …

We have expressed a series of truncated spike (S) glycoproteins of SARS-CoV and found
that the N-terminus 14–502 residuals were sufficient to bind to SARS-CoV susceptible Vero …

Human angiotensin‐converting enzyme 2 (ACE2) is a functional receptor for SARS
coronavirus (SARS‐CoV). Here we identify the SARS‐CoV spike (S)‐protein‐binding site on …

In vitro infection of Vero E6 cells by SARS coronavirus (SARS-CoV) is blocked by
hexapeptide Tyr-Lys-Tyr-Arg-Tyr-Leu. The peptide also inhibits proliferation of coronavirus …

The trimeric SARS coronavirus (SARS-CoV) surface spike (S) glycoprotein consisting of
three S1-S2 heterodimers binds the cellular receptor angiotensin-converting enzyme 2 …